HER 2 POSITIVE BREAST CANCER
Clinical trials for HER 2 POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER 2 POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER 2 POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to wipe out breast cancer before surgery
Disease control OngoingThis study tests whether giving two targeted drugs, T-DM1 and pertuzumab, before surgery can completely eliminate early-stage HER2-positive breast cancer. About 164 participants with stage II or III disease will receive the drugs for 18 weeks, then undergo surgery. The main goal …
Matched conditions: HER 2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug duo aims to tackle Hard-to-Treat breast cancer
Disease control OngoingThis phase 2 trial tests the safety and effectiveness of combining sacituzumab govitecan (Trodelvy) with trastuzumab (Herceptin) in 28 people with HER2+ metastatic breast cancer that has worsened after treatment with trastuzumab deruxtecan. The goal is to see how many participant…
Matched conditions: HER 2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Adrienne G. Waks • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug cocktail shows promise in slowing HER2-Positive breast cancer
Disease control OngoingThis phase 3 trial tests whether adding the drug palbociclib to standard anti-HER2 therapy and hormone therapy can help people with HR+/HER2+ metastatic breast cancer live longer without their cancer getting worse. About 518 participants who have already received initial treatmen…
Matched conditions: HER 2 POSITIVE BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can we predict Chemo's heart harm? new study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 700 breast cancer patients to understand how chemotherapy affects the heart. Researchers use echocardiograms and blood tests to find early signs of heart damage. The goal is to better predict and prevent cardiotoxicity in cancer treatment.
Matched conditions: HER 2 POSITIVE BREAST CANCER
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC